123 related articles for article (PubMed ID: 37043935)
1. Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study.
Sogabe M; Okahisa T; Kagawa M; Ueda H; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Taniguchi T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
Clin Nutr; 2023 May; 42(5):810-816. PubMed ID: 37043935
[TBL] [Abstract][Full Text] [Related]
2. Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.
Sogabe M; Okahisa T; Kagawa M; Kashihara T; Fujmoto S; Kawaguchi T; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Kawano Y; Sato Y; Nakasono M; Takayama T
Eur J Clin Invest; 2024 Apr; ():e14221. PubMed ID: 38634705
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females.
Sogabe M; Okahisa T; Kurihara T; Kagawa M; Ueda H; Kawaguchi T; Fukuya A; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Taniguchi T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
Sci Rep; 2022 Sep; 12(1):16048. PubMed ID: 36163355
[TBL] [Abstract][Full Text] [Related]
4. Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality.
van Kleef LA; de Knegt RJ; Brouwer WP
Hepatology; 2023 Mar; 77(3):942-948. PubMed ID: 35776631
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction-associated fatty liver disease and heavy alcohol consumption increase mortality:A nationwide study.
Cho SH; Kim S; Oh R; Kim JY; Lee YB; Jin SM; Hur KY; Kim G; Kim JH
Hepatol Int; 2024 May; ():. PubMed ID: 38806774
[TBL] [Abstract][Full Text] [Related]
6. Association of the Metabolic Dysfunction-Associated Fatty Liver Disease with Serum Uric Acid-to-Creatinine Ratio.
Han AL; Lee HK
Metab Syndr Relat Disord; 2022 Sep; 20(7):370-376. PubMed ID: 35796698
[No Abstract] [Full Text] [Related]
7. Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease.
Zhu Y; Xu X; Fan Z; Ma X; Rui F; Ni W; Hu X; Gu Q; Shi J; Wu C; Yeo YH; Li J
Liver Int; 2024 Mar; 44(3):865-875. PubMed ID: 38263792
[TBL] [Abstract][Full Text] [Related]
8. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
Yamamura S; Eslam M; Kawaguchi T; Tsutsumi T; Nakano D; Yoshinaga S; Takahashi H; Anzai K; George J; Torimura T
Liver Int; 2020 Dec; 40(12):3018-3030. PubMed ID: 32997882
[TBL] [Abstract][Full Text] [Related]
9. Influence of Alcohol Consumption on the Development of Erosive Esophagitis in Both Sexes: A Longitudinal Study.
Sogabe M; Okahisa T; Kagawa M; Ueda H; Kagemoto K; Tanaka H; Kida Y; Tomonari T; Taniguchi T; Miyamoto H; Sato Y; Nakasono M; Takayama T
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432447
[TBL] [Abstract][Full Text] [Related]
10. Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver disease.
Sogabe M; Okahis T; Kagawa M; Sei M; Ueda H; Yokoyama R; Kagemoto K; Tanaka H; Kida Y; Nakamura F; Tomonari T; Okamoto K; Miyamoto H; Sato Y; Nakasono M; Takayama T
Diabetes Metab Syndr; 2024 May; 18(5):103036. PubMed ID: 38754333
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
12. Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study.
Wu S; Li Y; Zhang Y; Su X; Zuo Y; Chen G; Xu G; Chen S; He Y; Wang A
Circ Heart Fail; 2024 Feb; 17(2):e010841. PubMed ID: 38348678
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease.
Fujii H; Nakamura N; Fukumoto S; Kimura T; Nakano A; Nadatani Y; Tauchi Y; Nishii Y; Takashima S; Kamada Y; Watanabe T; Kawada N
Liver Int; 2022 May; 42(5):995-1004. PubMed ID: 34995404
[TBL] [Abstract][Full Text] [Related]
15. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
16. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
[TBL] [Abstract][Full Text] [Related]
17. Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.
Miyake T; Kumagi T; Hirooka M; Furukawa S; Yoshida O; Koizumi M; Yamamoto S; Watanabe T; Yamamoto Y; Tokumoto Y; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
J Gastroenterol; 2016 Nov; 51(11):1090-1100. PubMed ID: 26971094
[TBL] [Abstract][Full Text] [Related]
18. Roles of alcohol consumption in fatty liver: a longitudinal study.
Moriya A; Iwasaki Y; Ohguchi S; Kayashima E; Mitsumune T; Taniguchi H; Ando M; Yamamoto K
J Hepatol; 2015 Apr; 62(4):921-7. PubMed ID: 25433160
[TBL] [Abstract][Full Text] [Related]
19. A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease.
Yang C; He Q; Chen Z; Qin JJ; Lei F; Liu YM; Liu W; Chen MM; Sun T; Zhu Q; Wu Y; Zhuo M; Cai J; Mao W; Li H
Front Endocrinol (Lausanne); 2022; 13():821689. PubMed ID: 35250880
[TBL] [Abstract][Full Text] [Related]
20. Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China.
Chang M; Shao Z; Wei W; Shen P; Shen G
Front Endocrinol (Lausanne); 2023; 14():1241169. PubMed ID: 37822594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
